60 related articles for article (PubMed ID: 22912432)
1. Utility of DPX2 cells for predicting CYP3A induction-mediated drug-drug interactions and associated structure-activity relationships.
Fahmi OA; Raucy JL; Ponce E; Hassanali S; Lasker JM
Drug Metab Dispos; 2012 Nov; 40(11):2204-11. PubMed ID: 22912432
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development.
Sinz MW
Drug Metab Rev; 2013 Feb; 45(1):3-14. PubMed ID: 23330538
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
Vrzal R; Kubesova K; Pavek P; Dvorak Z
Toxicol Lett; 2010 Mar; 193(2):183-8. PubMed ID: 20080160
[TBL] [Abstract][Full Text] [Related]
4. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss).
Wassmur B; Gräns J; Kling P; Celander MC
Aquat Toxicol; 2010 Oct; 100(1):91-100. PubMed ID: 20719396
[TBL] [Abstract][Full Text] [Related]
5. The Chinese herbal medicine Sophora flavescens activates pregnane X receptor.
Wang L; Li F; Lu J; Li G; Li D; Zhong XB; Guo GL; Ma X
Drug Metab Dispos; 2010 Dec; 38(12):2226-31. PubMed ID: 20736322
[TBL] [Abstract][Full Text] [Related]
6. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation.
Zhang H; LeCulyse E; Liu L; Hu M; Matoney L; Zhu W; Yan B
Arch Biochem Biophys; 1999 Aug; 368(1):14-22. PubMed ID: 10415106
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells.
McGinnity DF; Zhang G; Kenny JR; Hamilton GA; Otmani S; Stams KR; Haney S; Brassil P; Stresser DM; Riley RJ
Drug Metab Dispos; 2009 Jun; 37(6):1259-68. PubMed ID: 19307295
[TBL] [Abstract][Full Text] [Related]
8. Screening of a chemical library reveals novel PXR-activating pharmacologic compounds.
Ratajewski M; Grzelak I; Wiśniewska K; Ryba K; Gorzkiewicz M; Walczak-Drzewiecka A; Hoffmann M; Dastych J
Toxicol Lett; 2015 Jan; 232(1):193-202. PubMed ID: 25455453
[TBL] [Abstract][Full Text] [Related]
9. Chronic ethanol exposure downregulates hepatic expression of pregnane X receptor and P450 3A11 in female ICR mice.
Wang JP; Xu DX; Sun MF; Chen YH; Wang H; Wei W
Toxicology; 2005 Nov; 215(3):234-44. PubMed ID: 16126318
[TBL] [Abstract][Full Text] [Related]
10. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
Matheny CJ; Ali RY; Yang X; Pollack GM
Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
[TBL] [Abstract][Full Text] [Related]
11. Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasma.
Mao J; Mohutsky MA; Harrelson JP; Wrighton SA; Hall SD
Drug Metab Dispos; 2011 Apr; 39(4):591-602. PubMed ID: 21212240
[TBL] [Abstract][Full Text] [Related]
12. Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR).
Jacobs MN; Nolan GT; Hood SR
Toxicol Appl Pharmacol; 2005 Dec; 209(2):123-33. PubMed ID: 15885729
[TBL] [Abstract][Full Text] [Related]
13. The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A.
Ma X; Shah Y; Cheung C; Guo GL; Feigenbaum L; Krausz KW; Idle JR; Gonzalez FJ
Drug Metab Dispos; 2007 Feb; 35(2):194-200. PubMed ID: 17093002
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment for drug-drug interaction caused by metabolism-based inhibition of CYP3A using automated in vitro assay systems and its application in the early drug discovery process.
Watanabe A; Nakamura K; Okudaira N; Okazaki O; Sudo K
Drug Metab Dispos; 2007 Jul; 35(7):1232-8. PubMed ID: 17392390
[TBL] [Abstract][Full Text] [Related]
15. Nuclear receptor PXR: discovery of a pharmaceutical anti-target.
Kliewer SA
J Clin Invest; 2015 Apr; 125(4):1388-9. PubMed ID: 25831443
[TBL] [Abstract][Full Text] [Related]
16. Species-specific activation of nuclear receptors correlates with the response of liver drug metabolizing enzymes to EMD 392949 in vitro.
Mueller SO; Fery Y; Tuschl G; Schrenk D
Toxicol Lett; 2010 Mar; 193(1):120-3. PubMed ID: 20035846
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-activity relationship analysis for human pregnane X receptor for the prediction of CYP3A4 induction in human hepatocytes: structure-based comparative molecular field analysis.
Handa K; Nakagome I; Yamaotsu N; Gouda H; Hirono S
J Pharm Sci; 2015 Jan; 104(1):223-32. PubMed ID: 25381754
[TBL] [Abstract][Full Text] [Related]
18. Prediction of drug-drug interactions from in vitro induction data: application of the relative induction score approach using cryopreserved human hepatocytes.
Fahmi OA; Boldt S; Kish M; Obach RS; Tremaine LM
Drug Metab Dispos; 2008 Sep; 36(9):1971-4. PubMed ID: 18519654
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of calibration curve-based approaches to predict clinical inducers and noninducers of CYP3A4 with plated human hepatocytes.
Zhang JG; Ho T; Callendrello AL; Clark RJ; Santone EA; Kinsman S; Xiao D; Fox LG; Einolf HJ; Stresser DM
Drug Metab Dispos; 2014 Sep; 42(9):1379-91. PubMed ID: 24924386
[TBL] [Abstract][Full Text] [Related]
20. Multiplexing a high-throughput liability assay to leverage efficiencies.
Herbst J; Anthony M; Stewart J; Connors D; Chen T; Banks M; Petrillo EW; Agler M
Assay Drug Dev Technol; 2009 Jun; 7(3):294-303. PubMed ID: 19530896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
